Technical Analysis for BAX - Baxter International Inc.

Grade Last Price % Change Price Change
C 85.13 0.25% 0.21
BAX closed up 1.1 percent on Friday, April 9, 2021, on approximately normal volume.
Earnings due: Apr 28
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat
Historical BAX trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.25%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.25%
1,2,3 Pullback Bullish Bullish Swing Setup 1.35%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.35%
Down 3 Days in a Row Weakness 1.35%
Cup with Handle Other 0.25%
NR7 Range Contraction 0.25%
Inside Day Range Contraction 0.25%
Overbought Stochastic Strength -0.18%
1,2,3 Pullback Bullish Bullish Swing Setup 0.96%
Older End-of-Day Signals for BAX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Resistance 34 minutes ago
10 DMA Support about 2 hours ago
Non-ADX 1,2,3,4 Pullback Entry about 2 hours ago
1,2,3, Pullback Entry about 2 hours ago
Rose Above Previous Day's High about 2 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Baxter International Inc. Description

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in two segments, BioScience and Medical Products. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. It also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies; and to treat end-stage renal disease or irreversible kidney failure. In addition, this segment manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes products for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. serves hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and patients at home under physician supervision in the United States, Europe, the Asia-Pacific, Latin America, and Canada. The company sells its products through its direct sales force, as well as to and through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. Baxter International Inc. was founded in 1931 and is based in Deerfield, Illinois.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Infectious Diseases Disorders Dialysis Kidney Disease Medical Products Membrane Technology Medical Research Immune Disorders Nutrition Products Hemodialysis Renal Disease Hemophilia Syringe Burns Deerfield End Stage Renal Disease Infusion Pump Stage Renal Disease Antitrypsin Deficiency Kidney Nephrology Renal Dialysis Hemophilia A Drug Wholesalers Kidney Dialysis Specialty Pharmacy Kidney Failure Alpha 1 Antitrypsin Compounding Peritoneal Dialysis Biosurgery Products

Is BAX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 95.19
52 Week Low 74.79
Average Volume 2,576,811
200-Day Moving Average 81.14
50-Day Moving Average 79.68
20-Day Moving Average 82.69
10-Day Moving Average 85.00
Average True Range 1.36
ADX 34.73
+DI 28.67
-DI 13.95
Chandelier Exit (Long, 3 ATRs ) 82.46
Chandelier Exit (Short, 3 ATRs ) 81.05
Upper Bollinger Band 87.93
Lower Bollinger Band 77.45
Percent B (%b) 0.71
BandWidth 12.68
MACD Line 1.62
MACD Signal Line 1.59
MACD Histogram 0.0306
Fundamentals Value
Market Cap 43.38 Billion
Num Shares 511 Million
EPS 1.77
Price-to-Earnings (P/E) Ratio 48.06
Price-to-Sales 3.42
Price-to-Book 4.55
PEG Ratio 2.37
Dividend 0.98
Dividend Yield 1.15%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 86.53
Resistance 3 (R3) 86.35 85.64 86.26
Resistance 2 (R2) 85.64 85.23 85.73 86.17
Resistance 1 (R1) 85.28 84.98 85.46 85.46 86.08
Pivot Point 84.57 84.57 84.66 84.66 84.57
Support 1 (S1) 84.21 84.16 84.39 84.39 83.76
Support 2 (S2) 83.50 83.91 83.59 83.67
Support 3 (S3) 83.14 83.50 83.58
Support 4 (S4) 83.32